重要會議邀請演講:

(1).2011 International Symposium on Frontier Biomedical and Molecular Imaging 2011.Moderator (2).Invited speaker:Post-Congress Symposium of 2010 World Molecular Imaging Congress and the 2010 annual meeting of the Taiwanese Society for Molecular Imaging.“Multimodality Probes for PET, SPECT,MR and Optical Imagings”(3).Invited speaker: 2010Taiwan-Japan Bilateral Symposium-Nanotech and Health Care (Application and Commerization of Anti-PolyEthylene Glycol (Anti-PEG) Antibody in Biomedical Research) 2010. Sep. 23-24 (4). Chairperson:2010 International Cancer Biology Symposium Section II: Vascular Biology and Tumor Metastasis. (5). Chairperson: 2012 International Symposium on Clinical and Translational Cancer Research 2012,May 19.(6). 第十八屆分析化學技術交流研討會101527日,生醫檢測Section:Chairperson(7).Invited speaker: Ninth IUPAC International Symposium on Biomolecular Chemistry & Eighth International Symposium for Chinese Medicinal Chemists (ISCMC-8)August 25 - 29, 2012  (8). Invited speaker: 21屆細胞及分子生物新知研討會-墾丁冬令營」之「Protein Structure and Function」主題之演講講員(9). Invited speaker:The 2nd Forum on Innovative Therapeutics Discovery 2013 Taipei, National Taiwan University (第二屆海峽兩岸創新藥物研究論壇) (In Vivo Imaging of Protease Activity)(10).Invited speaker:1stInternational Workshop on Molecular Imaging in Vladivostok (Russia), October 20-26, 2013.“The application and commerization of Anti-PolyEthylene Glycol (Anti-PEG) Antibody in Biomedical Research”(11). Invited speaker:Antibody Therapeutic Conference:Design, Characterization and Translation, November 4-5, 2013 “Development of bispecificantibody and pro-antibody improves thespecificity and selectivity oftargeted therapy”; (12).Invited speaker:Antibody Therapeutics Conference 2015 Infectious Diseases, Oncology, and Immunology Friday, November 6 Proteases (MMP2/9) Enhance the Affinity and Therapeutic Efficacy of Targeted Antibody; (13).Moderator : Dr. Tian-Lu Cheng;  Antibody Drug Development Conference. 2016 / 10; (14).Invited speaker: Antibody Therapeutics Conference 2017 ~ Oncology, Immunology, and Infectious Diseases~ November 3rd, 2017XenoComputer: Develop fully humanized antibody drugs by computer-aided human V(D)J recombination

 

擔任國際重要學會理監事、國際知名學術期刊編輯、評審委員

(1).AICR Grant Applications Reviewer (2010)(2). Reviewer for Cytokine (2010)  (3). Reviewer for Molecular Imaging (2011)  (4). Reviewer for Journal of Nuclear Medicine (2011)  (5). Reviewer for Cancer Letters (2010)  (6). Reviewer for Fooyin Journal of Health Sciences (2010)  (7).Reviewer for Journal of Agricultural and Food Chemistry (2010)  (8). 98年度SBIR計畫生技領域之主審委員.  (9). 99年度SBIR計畫生技領域之主審委員.  (10). 100年度SBIR計畫生技領域之主審委員.  (11). 101年度「小型企業創新研發計畫(SBIR)」生技領域之審查委員(12). Taiwan Genomic Medicine and Biomarker Society, Director (2010~2013) (13). Genomic Medicine, Biomarkers,and Health Sciences. 2011~2013 Associate Editors (14). National Experimental Animal Center, the fifth advisory committee (2011~2012 (15). Reviewer for Journal of Biotechnology (2012) (16).Fooyin Journal of Health SciencesAcademic Journal Editorial Board 98/5~103/4 (17).Reviewer for Journal: Molecular Pharmaceutics 17-Oct-2013(18). Reviewer for Journal: Biomacromolecules Oct-2013 (19). Reviewer for The Journal of Physical Chemistry (07-May-2014) (20). Reviewer for Analyst (AN-ART-03-2017-000470.R2, 18-Sep-2017); (21). Reviewer for Biomaterials (jbmt41595, 24 Aug 2017); (22). Reviewer for Oncotarget (16 Aug 2017); (23). Taiwan Genomic Medicine and Biomarker Society, Chairman of the board (2015~2017); (24).Taiwan antibody Association, Director (2016~2017); (25).Reviewer for Scientific Reports (2017 SREP-17-08476A); (26).Reviewer for Molecular Pharmaceutics (28-Aug-2017 mp-2017-00734j); (27).Reviewer for Biotechnology Journal (2017 03-Apr-2017); (28).Reviewer for Trends in Cancer Research (26 March 2017); (29).Reviewer for Molecular Pharmaceutics (12-Mar-2017 mp-2017-00151u); (30).Reviewer for International Journal of Nanomedicine. (18 Mar 2017.  ID: 136453); (31).Reviewer for Biomacromolecules (01-Mar-2017   bm-2017-00275n); (32).Reviewer for Analytical Chemistry (22-Jan-2017  ac-2016-04058s.R1); (33).Reviewer for Molecular Pharmaceutics (14-Nov-2016 mp-2016-00964g); (34).Reviewer for Analytical Chemistry (20-Oct-2016  ac-2016-04058s); (35).Reviewer for Molecular Imaging and Biology(2016  MIBI-D-16-00102R1); (36).Reviewer for Molecular Pharmaceutics ( 20-Oct-2014 mp-2014-006189); (37).Reviewer for The Journal of Physical Chemistry ( 30-Jun-2014  jp-2014-041713.R1); (38).Reviewer for Biomarkers and Genomic Medicine (2014 BGM-D-14-00033); (39).Reviewer for Biomarkers and Genomic Medicine (2013 BGM-D-13-00021); (40).Reviewer for Molecular Pharmaceutics (01-Oct-2013 mp-2013-00569k); (41).Reviewer for Biomacromolecules (01-Oct-2013  bm-2013-01452v)